Clinical Trial Update: Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and Italy-Manufactured Evenity in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial comparing pharmacokinetics, pharmacodynamics, safety, and immunogenicity of SAL023 versus Italy-manufactured Evenity in healthy subjects. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Evenity (romosozumab)
• SAL023

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Osteoporosis | Phase 1 | Status: ENROLLING_BY_INVITATION